These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2633468)

  • 1. [Experimental study of the effectiveness of inactivated chromatographic influenza vaccine prepared from the native and recombinant strains of influenza virus].
    Rozaeva NR; Bichurina MA; Fridman EA
    Vopr Virusol; 1989; 34(6):738-41. PubMed ID: 2633468
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.
    Rota PA; De BK; Shaw MW; Black RA; Gamble WC; Kendal AP
    Virus Res; 1990 Apr; 16(1):83-93. PubMed ID: 2349834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of protection against H5N1 influenza virus in mouse offspring provided by maternal vaccination with HA DNA and inactivated vaccine.
    Zhang F; Fang F; Chang H; Peng B; Wu J; Chen J; Wang H; Chen Z
    Arch Virol; 2013 Jun; 158(6):1253-65. PubMed ID: 23385327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency of an inactivated influenza vaccine prepared from A/duck/Hong Kong/960/1980 (H6N2) against a challenge with A/duck/Vietnam/OIE-0033/2012 (H6N2) in mice.
    Nishi T; Sakoda Y; Okamatsu M; Kida H
    Arch Virol; 2014 Oct; 159(10):2567-74. PubMed ID: 24824346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
    Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
    Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye mucosa: an efficient vaccine delivery route for inducing protective immunity.
    Seo KY; Han SJ; Cha HR; Seo SU; Song JH; Chung SH; Kweon MN
    J Immunol; 2010 Sep; 185(6):3610-9. PubMed ID: 20709955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus.
    Vanlandschoot P; Maertens G; Jou WM; Fiers W
    Vaccine; 1993 Sep; 11(12):1185-7. PubMed ID: 8256499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice.
    Suzuki M; Okamatsu M; Hiono T; Matsuno K; Sakoda Y
    J Vet Med Sci; 2017 Nov; 79(11):1815-1821. PubMed ID: 28993601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.
    Wesley RD; Tang M; Lager KM
    Vaccine; 2004 Sep; 22(25-26):3427-34. PubMed ID: 15308368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
    Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Live attenuated and inactivated influenza vaccines: data from direct comparative studies].
    Kashirina OS; Vasil'ev IuM
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):103-19. PubMed ID: 24738303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
    Minke JM; Toulemonde CE; Dinic S; Cozette V; Cullinane A; Audonnet JC
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S76-80. PubMed ID: 17559865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus.
    Suda T; Kawano M; Nogi Y; Ohno N; Akatsuka T; Matsui M
    Antiviral Res; 2011 Sep; 91(3):252-8. PubMed ID: 21722671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanisms of the formation of heterologous resistance in peroral immunization with a complex anti-influenza preparation].
    Markevich NA; Maslennikova II; Pokrovskaia EE; Osipova MV; Ispolatova AV
    Vestn Ross Akad Med Nauk; 1996; (1):51-4. PubMed ID: 8907427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination.
    Surls J; Nazarov-Stoica C; Kehl M; Casares S; Brumeanu TD
    Vaccine; 2010 Oct; 28(45):7319-30. PubMed ID: 20832492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.